SOD1G93A transgenic mouse CD4+ T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment

Brain, Behavior, and Immunity

Volumn 40, Issue , 2014, Pages 55-60

  Mesnard Hoaglin, Nichole A ^a,b,c,f   Xin, Junping ^a,b   Haulcomb, Melissa M ^c,d   Batka, Richard J ^c,d   Sanders, Virginia M ^e   Jones, Kathryn J ^c,d  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

^d RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

ALS; APC; Axotomy; Immune; Motoneuron; SOD1; T cell

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; FACIAL NERVE; FACIAL NERVE AXOTOMY; FACIAL NERVE NUCLEUS; FEMALE; IMMUNOCOMPETENT CELL; LYMPHOCYTE DIFFERENTIATION; MICROENVIRONMENT; MOTONEURON; MOUSE; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL; T LYMPHOCYTE ACTIVATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; C57BL MOUSE; FACIAL NERVE INJURY; GENETICS; HUMAN; IMMUNOLOGY; PATHOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION;

COPPER ZINC SUPEROXIDE DISMUTASE; DNA BINDING PROTEIN; RAG2 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE;

ADOPTIVE TRANSFER; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXOTOMY; CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; FACIAL NERVE INJURIES; FACIAL NUCLEUS; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; SUPEROXIDE DISMUTASE;

EID: 84904120588     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.05.019     Document Type: Article

References (36)

1. Appel S.H., Beers D.R., Henkel J.S. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?. Trends Immunol. 2010, 31:7-17.
2. Banerjee R., Mosley R.L., Reynolds A.D., Dhar A., Jackson-Lewis V., Gordon P.H., Przedborski S., Gendelman H.E. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE 2008, 3:e2740.
3. Beers D.R., Henkel J.S., Zhao W., Wang J., Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15558-15563.
4. Beers D.R., Zhao W., Liao B., Kano O., Wang J., Huang A., Appel S.H., Henkel J.S. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav. Immun. 2011, 25:1025-1035.
5. Byram S.C., Serpe C.J., Pruett S.B., Sanders V.M., Jones K.J. Natural killer cells do not mediate facial motoneuron survival after facial nerve transection. Brain Behav. Immun. 2003, 17:417-425.
6. Byram S.C., Carson M.J., DeBoy C.A., Serpe C.J., Sanders V.M., Jones K.J. CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J. Neurosci. 2004, 24:4333-4339.
7. Chiu I.M., Chen A., Zheng Y., Kosaras B., Tsiftsoglou S.A., Vartanian T.K., Brown R.H., Carroll M.C. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17913-17918.
8. Chiu I.M., Phatnani H., Kuligowski M., Tapia J.C., Carrasco M.A., Zhang M., Maniatis T., Carroll M.C. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20960-20965.
9. DeBoy C.A., Byram S.C., Serpe C.J., Wisuri D., Sanders V.M., Jones K.J. CD4+CD25+ regulatory T cells and CD1-restricted NKT cells do not mediate facial motoneuron survival after axotomy. J. Neuroimmunol. 2006, 176:34-38.
10. Deboy C.A., Xin J., Byram S.C., Serpe C.J., Sanders V.M., Jones K.J. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells. Exp. Neurol. 2006, 201:212-224.
11. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185:232-240.
12. Graves M.C., Fiala M., Dinglasan L.A., Liu N.Q., Sayre J., Chiappelli F., van Kooten C., Vinters H.V. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2004, 5:213-219.
13. Gurney M.E. Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 1994, 331:1721-1722.
14. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
15. Haulcomb M.M., Mesnard N.A., Batka R.J., Alexander T.D., Sanders V.M., Jones K.J. Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in ALS transgenic mice. J. Comp. Neurol. 2014, 522(10):2349-2376.
16. Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007, 28:154-164.
17. Henkel J.S., Engelhardt J.I., Siklos L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., Appel S.H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 2004, 55:221-235.
18. Jinno S., Yamada J. Using comparative anatomy in the axotomy model to identify distinct roles for microglia and astrocytes in synaptic stripping. Neuron Glia Biol. 2011, 7:55-66.
19. Jones K.J., LaVelle A. Changes in nuclear envelope invaginations in axotomized immature and mature hamster facial motoneurons. Brain Res. 1985, 353:241-249.
20. Jones K.J., Serpe C.J., Byram S.C., Deboy C.A., Sanders V.M. Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury. Brain Behav. Immun. 2005, 19:12-19.
21. Kennel P.F., Finiels F., Revah F., Mallet J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice. An electromyographic study. NeuroReport 1996, 7:1427-1431.
22. Mesnard N.A., Sanders V.M., Jones K.J. Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice. J. Comp. Neurol. 2011, 519:3488-3506.
23. Mesnard N.A., Hauclomb M.M., Tanzer L., Sanders V.M., Jones K.J. Delayed functional recovery in presymptomatic mSOD1-G93A mice following facial nerve crush axotomy. J. Neurodegen. Regen. 2013, 4:21-25.
24. Moran L.B., Graeber M.B. The facial nerve axotomy model. Brain Res. Brain Res. Rev. 2004, 44:154-178.
25. O'Reilly S.A., Roedica J., Nagy D., Hallewell R.A., Alderson K., Marklund S.L., Kuby J., Kushner P.D. Motor neuron-astrocyte interactions and levels of Cu, Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 1995, 131:203-210.
26. Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011, 10:253-263.
27. Rafalowska J., Dziewulska D., Gadamski R., Chrzanowska H., Modrzewska-Lewczuk M., Grieb P. Is the spinal cord motoneuron exclusively a target in ALS? Comparison between astroglial reactivity in a rat model of familial ALS and in human sporadic ALS cases. Neurol. Res. 2010, 32:867-872.
28. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
29. Sanagi T., Yuasa S., Nakamura Y., Suzuki E., Aoki M., Warita H., Itoyama Y., Uchino S., Kohsaka S., Ohsawa K. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J. Neurosci. Res. 2010, 88:2736-2746.
30. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J. Neurosci. 1999, 19:RC7.
31. Serpe C.J., Sanders V.M., Jones K.J. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J. Neurosci. Res. 2000, 62:273-278.
32. Serpe C.J., Tetzlaff J.E., Coers S., Sanders V.M., Jones K.J. Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. Brain Behav. Immun. 2002, 16:808-812.
33. Serpe C.J., Coers S., Sanders V.M., Jones K.J. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav. Immun. 2003, 17:393-402.
34. Troost D., Das P.K., van den Oord J.J., Louwerse E.S. Immunohistological alterations in muscle of patients with amyotrophic lateral sclerosis: mononuclear cell phenotypes and expression of MHC products. Clin. Neuropathol. 1992, 11:115-120.
35. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 2004, 15:601-609.
36. Zang D.W., Lopes E.C., Cheema S.S. Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. J. Neurosci. Res. 2005, 79:694-699.